BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• BioMidwest

  Boehringer Ingelheim Corporation and Eli Lilly and Company to Feature 30 Presentations on Type 1 and Type 2 Diabetes at the 72nd American Diabetes Association Scientific Sessions

  June 5, 2012

   · 

  1 min read
• Pharm Country

  ERYtech Pharma Receives € 7 Million from OSEO to Lead the TEDAC Personalized Medicine Project in Cancer

  June 5, 2012

   · 

  1 min read
• German University Study Endorses Uscom Limited Australia’s Non-Invasive Ultra-Sound Cardiac Output Monitor For Critical Care Patients

  June 5, 2012

   · 

  1 min read
• Oramed Pharmaceuticals Inc. to Present at the 72nd Scientific Sessions of the American Diabetes Association in Philadelphia, PA, June 8-12, 2012

  June 5, 2012

   · 

  1 min read
• Biotech Beach

  Amylin Pharmaceuticals, Inc. to Present Data on BYDUREON™, BYETTA®and SYMLIN® at the American Diabetes Association 2012 Meeting

  June 5, 2012

   · 

  1 min read
• Business

  Dyax Corp. Announces Partnership With Taiba for Distribution of Kalbitor®(ecallantide) in the Middle East

  June 5, 2012

   · 

  1 min read
• Pharm Country

  PhaseBio Pharmaceuticals, Inc. Received an Additional $23 Million With Completion of the Third Tranche of a Series B Financing for Advancement of Metabolic and Cardiovascular Product Portfolio

  June 5, 2012

   · 

  2 min read
• Biotech Bay

  2012 Velos, Inc. Annual Meeting: Collaboration & Innovation in Action

  June 5, 2012

   · 

  3 min read
• Business

  XenoPort, Inc. Announces Key Management Promotions

  June 5, 2012

   · 

  1 min read
• BioMidwest

  Prospective Study Shows Favorable Overall Survival in Cancer of Unknown Primary Patients With Therapy Directed by bioTheranostics’ CancerTYPE ID®

  June 5, 2012

   · 

  1 min read